| Product Code: ETC12465007 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Immunoglobulin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Immunoglobulin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Immunoglobulin Market - Industry Life Cycle |
3.4 Israel Immunoglobulin Market - Porter's Five Forces |
3.5 Israel Immunoglobulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Immunoglobulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Immunoglobulin Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Immunoglobulin Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.9 Israel Immunoglobulin Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Israel Immunoglobulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of immunodeficiency disorders in Israel |
4.2.2 Growing awareness and acceptance of immunoglobulin therapy |
4.2.3 Technological advancements in immunoglobulin production and purification |
4.3 Market Restraints |
4.3.1 High cost associated with immunoglobulin therapy |
4.3.2 Stringent regulatory requirements for immunoglobulin products |
4.3.3 Limited availability of immunoglobulin products in some regions of Israel |
5 Israel Immunoglobulin Market Trends |
6 Israel Immunoglobulin Market, By Types |
6.1 Israel Immunoglobulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Immunoglobulin Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Immunoglobulin Market Revenues & Volume, By IgG (Immunoglobulin G), 2021 - 2031F |
6.1.4 Israel Immunoglobulin Market Revenues & Volume, By IgA (Immunoglobulin A), 2021 - 2031F |
6.1.5 Israel Immunoglobulin Market Revenues & Volume, By IgM (Immunoglobulin M), 2021 - 2031F |
6.1.6 Israel Immunoglobulin Market Revenues & Volume, By IgE (Immunoglobulin E), 2021 - 2031F |
6.1.7 Israel Immunoglobulin Market Revenues & Volume, By IgD (Immunoglobulin D), 2021 - 2031F |
6.2 Israel Immunoglobulin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Immunoglobulin Market Revenues & Volume, By Primary Immunodeficiency, 2021 - 2031F |
6.2.3 Israel Immunoglobulin Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.2.4 Israel Immunoglobulin Market Revenues & Volume, By Infectious Disease Treatment, 2021 - 2031F |
6.2.5 Israel Immunoglobulin Market Revenues & Volume, By Allergic Reactions, 2021 - 2031F |
6.2.6 Israel Immunoglobulin Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.3 Israel Immunoglobulin Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Immunoglobulin Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Immunoglobulin Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 Israel Immunoglobulin Market Revenues & Volume, By Blood Banks, 2021 - 2031F |
6.3.5 Israel Immunoglobulin Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Israel Immunoglobulin Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.4 Israel Immunoglobulin Market, By Mode of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Immunoglobulin Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.4.3 Israel Immunoglobulin Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Israel Immunoglobulin Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.4.5 Israel Immunoglobulin Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.4.6 Israel Immunoglobulin Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.5 Israel Immunoglobulin Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Immunoglobulin Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.5.3 Israel Immunoglobulin Market Revenues & Volume, By Bulk Purchases, 2021 - 2031F |
6.5.4 Israel Immunoglobulin Market Revenues & Volume, By Research Contracts, 2021 - 2031F |
6.5.5 Israel Immunoglobulin Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.6 Israel Immunoglobulin Market Revenues & Volume, By Specialty Distributors, 2021 - 2031F |
7 Israel Immunoglobulin Market Import-Export Trade Statistics |
7.1 Israel Immunoglobulin Market Export to Major Countries |
7.2 Israel Immunoglobulin Market Imports from Major Countries |
8 Israel Immunoglobulin Market Key Performance Indicators |
8.1 Percentage increase in the number of patients receiving immunoglobulin therapy |
8.2 Rate of adoption of new immunoglobulin products in the market |
8.3 Number of clinical studies or trials conducted on immunoglobulin therapy in Israel |
9 Israel Immunoglobulin Market - Opportunity Assessment |
9.1 Israel Immunoglobulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Immunoglobulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Immunoglobulin Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Immunoglobulin Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.5 Israel Immunoglobulin Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Israel Immunoglobulin Market - Competitive Landscape |
10.1 Israel Immunoglobulin Market Revenue Share, By Companies, 2024 |
10.2 Israel Immunoglobulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here